RUNX2 has been identified as the master regulator switch in osteoblast differentiation and calcification [42] whereas SOX9 has been shown to mediate processes of chondrogenesis and prevents CAVD [20, 43, 44]. Here, RUNX2 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.